Public research preview
Thomas R. Suozzi, Representative disclosure: CVS Health Corporation Common Stock (CVS)
Disclosed a sell transaction in CVS Health Corporation Common Stock (CVS). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 12 Nov 2024, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 19 days
Timeline
Transaction date
24 Oct 2024
Public disclosure
12 Nov 2024
Now
Tracked today
Filing delay: 19 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 10 Jun 2026
Stock path
CVS from pre-transaction context through latest close.
Transaction
24 Oct 2024 · 52,915 USD · Not public yet
System decision
Would not buy — The strategy's filters reject this signal. Failed filters: Buy disclosure.
- Not public yet
- Would not buy
- Observed transaction close
- 52,915
- Observed disclosure close
- 50,944
- Observed latest close
- 97,08
- Pre-disclosure move
- -3.7%
- Post-disclosure move
- +90.6%
- Market-adjusted move
- +90.6%
- Pre-disclosure peak run-up
- +9.8%
- Retrace from peak
- -12.3%
Why Copy Window is Probably too late
Supporting factors
- Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 12 Nov 2024, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%